Trump mulls new tariffs over foreign drug pricing: Report
The Trump administration is launching a new investigation into drug pricing practices of US trading partners, potentially leading to tariffs. This Section 301 investigation will determine if these countries are underpaying for drugs, while US patients currently pay the most. Trump has previously threatened a 100% tariff on imported drugs and is pressuring pharmaceutical companies to lower prices.